Crosbys Drugs Inc.

Form 483 issued September 16, 2016 · Columbus, Ohio

Inspection
Sep 12 – Sep 16, 2016
Investigator
Matthew B. Casale
Observations
8
Pages
3
FEI number
1530045

In short: On September 16, 2016, FDA issued a Form 483 with 8 observations to Crosbys Drugs Inc. in Columbus, Ohio (FEI 1530045) after an inspection that ran Sep 12 – Sep 16, 2016. The investigator was Matthew B. Casale. Most observations concern production and materials; the most-cited regulation is 21 CFR 211.94 (drug product containers and closures).

At a glance

Observations span 4 systems, led by production.

Production2
Materials2
Facilities & equipment2
Laboratory controls2

What FDA observed

Preview: the opening words of each observation
  1. 01

    Procedures designed to prevent microbiological contamination of dmg products pmporting to be sterile are not…

  2. 02

    Clothing of personnel engaged in the manufacturing, processing and packing of drug products is not appropriate…

  3. 03

    Dmg product containers and closures were not clean and sterilized and processed to remove pyrogenic properties…

  4. 04

    The flow of components and in-process materials though the building is not…

4 more observations

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Crosbys Drugs Inc.?

FDA listed 8 observations on this Form 483, mostly about production, materials and facilities & equipment. The most-cited regulation is 21 CFR 211.94 (drug product containers and closures). The opening words of each observation are shown on this page.

Who inspected Crosbys Drugs Inc.?

Matthew B. Casale is named on this Form 483, for the inspection of Sep 12 – Sep 16, 2016. Each investigator has a profile showing what they cite most.

When was Crosbys Drugs Inc. inspected by FDA?

The inspection ran Sep 12 – Sep 16, 2016, and the Form 483 is dated September 16, 2016.

How do I get the full Form 483 for Crosbys Drugs Inc.?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free